Stockreport

Bioventus reiterates 2025 guidance with 6%–8% organic growth target as PNS and PRP launches gain traction [Seeking Alpha]

Bioventus Inc. - Class A  (BVS) 
PDF CEO Robert Claypoole highlighted that Bioventus delivered a solid quarter, continuing to advance strategic priorities and reiterating full year guidance on all metrics. [Read more]